DCAT Names Officers - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

DCAT Names Officers


Lyra Myers, associate director and value creation agent at Roche, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: George Svokos, senior vice-president, product and portfolio management at Teva Pharmaceuticals U.S.A., as senior vice-president; Folker Ruchatz, senior vice-president, contract manufacturing business, biopharmaceuticals at Boehringer Ingelheim as finance officer; and Milton Boyer, president at OSO BioPharmaceuticals Manufacturing, LLC as vice-president. All will serve one-year terms.

DCAT is a nonprofit business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical, and related industries. The association provides services, programs and activities designed to support the business development objectives of its membership.

Source: DCAT

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here